Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy (ASSIST-VLA)

NCT07346287 is registered in ClinicalTrials.gov with Stratpharma AG as lead sponsor.

NCT NCT07346287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07346287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy (ASSIST-VLA)
Lead sponsor
Stratpharma AG
Phase
Phase 4
Overall status
Completed
Start date
August 13, 2025
Completion date
February 19, 2026
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic vaginitis, genitourinary syndrome of menopause (gsm), vaginal atrophy